Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

This study has been completed.
Sponsor:
Collaborators:
Agency for Healthcare Research and Quality (AHRQ)
American Academy of Pediatrics
DARTNet Institute
Information provided by (Responsible Party):
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT01966068
First received: October 11, 2013
Last updated: August 30, 2016
Last verified: August 2016
  Purpose

This study will enroll parents/guardians of children who receive treatment at one of the pediatric primary care practice settings in the Pediatric Research in Office Settings (PROS) network or at the Children's Hospital of Philadelphia's Pediatric Research Consortium (PeRC) network.

The study will use an evidence-based conceptual model to study determinants of implementation success, implementation outcomes, and health care outcomes resulting from implementing an already functional, electronic health record (EHR)-linked asthma portal, MyAsthma. The study will measure the portal's feasibility and determine the impact on providing asthma education and fostering patient engagement as well as the ability to collect patient-reported outcomes for children, evaluate medication use and side effects and track parents' preferences and goals.


Condition Intervention
Asthma
Other: MyAsthma Web Portal

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Informing Policy to Implement Pediatric Family Engagement in Meaningful Use Stage 3

Resource links provided by NLM:


Further study details as provided by Children's Hospital of Philadelphia:

Primary Outcome Measures:
  • Difference Between Number of Families Who Adopted MyAsthma Portal Use and Number of Families With Sustained Use [ Time Frame: Up to 6 Months ] [ Designated as safety issue: No ]
    Implementation success was measure by comparing the of the number of enrolled families (parent/guardian) who logged on to the MyAsthma Portal once (adoption) with the number of enrolled families (parent/guardian) who logged on more than once (sustained use). Parents/guardians were asked to log on and complete the same survey on the MyAsthma Portal 3 times during a 6 month period.


Enrollment: 294
Study Start Date: October 2013
Study Completion Date: February 2015
Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MyAsthma Web Portal
The portal, MyAsthma, will provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' concerns and goals. Parents will log into the web portal each month (for a total of 3 portal visits in 6 months), and the information entered by parents will be shared through the electronic health record with the child's primary care provider.
Other: MyAsthma Web Portal
Parents will log on to the MyAsthma Web Portal up to three different times over a 6 month period. During each portal visit, parents will be asked to complete a survey which will include questions regarding their views on treatment preferences, goals, asthma control, and medications for their child with asthma.

Detailed Description:
This study uses a newly published, evidence-based conceptual model to study the determinants of implementation success, implementation outcomes, and health care outcomes resulting from implementing an asthma portal, MyAsthma, in the national, Agency for Health Care Research and Quality(AHRQ)-funded, Center for Pediatric Practice Research and Learning. Technically, the portal will be implemented with 2 innovative approaches that facilitate rapid cycle evaluation in multiple Electronic Health Records (EHRs). Although many patient portals are simple vehicles for transferring information about upcoming appointments, test results or laboratory findings, the asthma portal in this project extends this basic functionality to provide asthma education, collect patient-reported outcomes, evaluate medication use and side effects, and track parents' preferences and goals. Because asthma is an AHRQ priority condition which addresses three AHRQ priority criteria (children, low income, and special health care needs), our study will use this population to focus on stage 3 Meaningful Use (MU3) objectives. It is the hope that by conducting this study, translational knowledge will be gained to make recommendations for practice implementation and actionable policy statements.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria For Parents/Guardians:

  1. Parent/guardian of a child who:

    • Is between the ages of 6-12 years old
    • Has a diagnosis of asthma on his/her problem list at the time of recruitment
    • Has had an office visit with asthma as a diagnosis within the past 12 months
  2. Must be able to speak and read English

Exclusion Criteria For Parents/Guardians:

  1. Child has not had an office visit for asthma with in the last 12 months
  2. Parent or guardian does not speak or read English
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01966068

Locations
United States, Illinois
Pediatrick Research in Office Settings (PROS)
Elk Grove Village, Illinois, United States, 60007
United States, Pennsylvania
Pediatric Research Consortium of the Children's Hospital of Philadelphia (PeRC)
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
Children's Hospital of Philadelphia
Agency for Healthcare Research and Quality (AHRQ)
American Academy of Pediatrics
DARTNet Institute
Investigators
Principal Investigator: Alexander Fiks, MD, MSCE Children's Hospital of Philadelphia
  More Information

Responsible Party: Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier: NCT01966068     History of Changes
Other Study ID Numbers: 13-010285 
Study First Received: October 11, 2013
Results First Received: July 13, 2016
Last Updated: August 30, 2016
Health Authority: United States: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: Undecided

Keywords provided by Children's Hospital of Philadelphia:
Asthma
Pediatrics
Health Technology
Meaningful Use Stage-3
Web Portal

ClinicalTrials.gov processed this record on December 02, 2016